文献速递心力衰竭与心肌病

英格兰心衰结局的种族差异:全民医疗体系下专科照护的作用

Ethnicity and Heart Failure Outcomes in England: Role of Specialist Care in a Universal Health System.
PubMed 文献 · J Am Coll Cardiol · 2026-01-01

基于2018至2023年英格兰国家心衰审计等常规数据,纳入239,890例因心衰住院患者,按种族分为白人、黑人、亚裔及混合/其他组。研究发现,非白人患者接受指南推荐药物治疗的比例更高,且校正年龄、性别、社会经济因素及心衰严重程度后,所有非白人种族组的长期死亡率均低于白人组。

要点

  • 非白人心衰患者出院时接受指南推荐药物治疗的比例优于白人患者。
  • 校正混杂因素后,黑人、亚裔及混合/其他种族的死亡风险均低于白人。
  • 约90%的死亡由心血管或呼吸系统原因导致。

核心结论

  • 在全民医疗体系中,非白人心衰住院患者接受了更好的药物管理,且与更好的长期结局相关。

研究设计与样本

  • 利用2018至2023年英格兰国家心衰审计、医院 episode 统计及死亡登记常规数据进行分析。
  • 纳入239,890例心衰住院患者,按种族分为白人215,800例、黑人6,610例、亚裔12,940例、混合/其他4,540例。

主要发现

  • 白人患者中位年龄81岁,黑人75岁,亚裔77岁,混合/其他75岁。
  • 所有种族组中约50%为射血分数降低的心衰。
  • 白人射血分数降低的心衰患者出院时接受指南推荐治疗的可能性最低。
  • 中位随访68周,白人死亡率为57%,黑人43%,亚裔48%,混合/其他42%。
  • 校正后黑人死亡风险HR为0.81(95%CI:0.78-0.84),亚裔HR为0.77(95%CI:0.75-0.79),混合/其他HR为0.72(95%CI:0.69-0.75)。

临床怎么用

  • 应关注白人心衰住院患者中指南推荐药物治疗的落实差距。
  • 非白人种族的心衰患者预后并不必然更差,照护质量可能是关键影响因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Poorer cardiovascular outcomes among ethnic minorities have been reported, particularly during the COVID-19 pandemic. However, the relationship between ethnicity and quality of care after hospitalization for heart failure (HF) and long-term outcomes is largely unknown. OBJECTIVES: The aim of this analysis is to investigate quality of care and longer-term outcomes of patients hospitalized with acute HF according to ethnicity. METHODS: Routinely collected data for England from the National Heart Failure Audit, National Health Service Hospital Episode Statistics, and Office for National Statistics death register from 2018 to 2023 were used to investigate the quality of care and outcomes after hospitalization with HF according to ethnicity. RESULTS: National Heart Failure Audit data for 239,890 patients admitted with HF were grouped by ethnicity as White (215,800), Black (6,610), Asian (12,940), and mixed/other (4,540), with median ages of 81 years (IQR: 73-88 years),75 years (IQR: 60-84 years), 77 years (IQR: 67-84 years), and 75 years (IQR: 61-84 years), respectively. Overall, patients had a median of 3 comorbidities (IQR: 2-4 comorbidities), with Asians having the greatest number. About 50% of patients had HF with reduced ejection fraction in all ethnic groups. For HF with reduced ejection fraction, White patients were least likely to be discharged on guideline-recommended therapies. Over a median follow-up of 68 weeks (IQR: 20-142 weeks), 122,980 (57%) White patients died, as did 2,860 (43%) Black patients, 6,270 (48%) Asian patients, and 1,900 (42%) patients of other/mixed ethnicity. About 90% of deaths were due to cardiovascular or respiratory causes. After adjusting for age, sex, socioeconomic factors, and variables associated with HF severity, all ethnic groups had lower mortality compared with White patients, including those who were Black (HR: 0.81; 95% CI: 0.78-0.84), Asian (HR: 0.77; 95% CI: 0.75-0.79), or from mixed/other ethnic groups (HR: 0.72; 95% CI: 0.69-0.75). CONCLUSIONS: In a universal health care system, treating an ethnically diverse population hospitalized for HF, non-White patients received better pharmacological management, which was associated with better long-term outcomes.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Cannata, Mizani, Bromage, et al. Ethnicity and Heart Failure Outcomes in England: Role of Specialist Care in a Universal Health System. J Am Coll Cardiol. 2026. PMID: 41848357. doi:10.1016/j.jacc.2025.12.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。